Open Access Pre-publication history

Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease

Gemma Bruera, Katia Cannita, Daniela Di Giacomo, Aude Lamy, Giancarlo Troncone, Antonella Dal Mas, Gino Coletti, Thierry Frébourg, Jean Christophe Sabourin, Mario Tosi, Corrado Ficorella and Enrico Ricevuto*

BMC Medicine 2012, 10:135  doi:10.1186/1741-7015-10-135

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 21 Apr 2012
Reviewer's Report Gianluca Masi 22 May 2012
Reviewer's Report Paolo Correale 13 Jun 2012
Resubmission - Version 2 Manuscript Author's comment 07 Jul 2012
Resubmission - Version 3 Manuscript Author's comment 11 Jul 2012
Reviewer's Report Gianluca Masi 25 Jul 2012
Reviewer's Report Paolo Correale 14 Sep 2012
Resubmission - Version 4 Manuscript Author's comment 20 Sep 2012
Resubmission - Version 5 Manuscript Author's comment 21 Sep 2012
Editorial acceptance 24 Sep 2012
Published 08 Nov 2012